| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |